Additionally, these medications are covered for the treatment of childhood obesity under Medicaids Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit
doi: 10.3389/fphys.2025.1613917 Received 17 April 2025 Revised 30 September 2025 Accepted 07 October 2025 Published 20 November 2025 Corrected 27 November 2025 Volume 16 - 2025 Edited by Elena Di Pierro, IRCCS Ca Granda Foundation Maggiore Policlinico Hospital, Italy Reviewed by Tiago L Duarte, Universidade do Porto, Portugal Hans Bumler, Charit University Medicine Berlin, Germany Updates Copyright 2025 Rose, Moore, Eskew, Vanacore, Hartson, Province, Skaff and Smith
Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes
Anxiety disorders
Most patients tolerate the combination safely because modern GLP-1 compounds have mild effects on kidney function when used at prescribed doses